Company news

Delcath Systems, Inc. news in 2026

Delcath Systems, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Delcath Systems to Participate in Upcoming Investor Conferences

October 27, 2026

Delcath Systems to Host Third Quarter 2026 Earnings Call

October 26, 2026

Delcath Systems Highlights Clinical Program Presentations at ESMO Congress 2026 and Independent Data on Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma

October 19, 2026

Delcath Systems Reports Second Quarter 2026 Results and Business Highlights

August 6, 2026

Delcath Systems to Participate at the Canaccord Genuity 46th Annual Growth Conference

July 27, 2026

Delcath Systems to Host Second Quarter 2026 Earnings Call

July 23, 2026

Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO in Liver-Dominant Metastatic Breast Cancer

July 10, 2026

Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer

July 9, 2026

Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts

May 26, 2026

Delcath Systems Reports First Quarter 2026 Results and Business Highlights

May 7, 2026

Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026

May 7, 2026

Delcath Systems to Host First Quarter 2026 Earnings Call

April 23, 2026

Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma

April 5, 2026

Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting

April 1, 2026

Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology

March 2, 2026

Delcath Systems Reports Fourth Quarter and Full Year 2025 Results

February 26, 2026

Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call

February 12, 2026

Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

January 27, 2026

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 21, 2026

Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

January 9, 2026

Calls in 2026

Decks in 2026